Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Fertility and Sterility

• Publication date

  1995-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0015-0282(16)57900-XPMID 7589632
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extending the use of gonadotropin-releasing hormone agonists: the emerging role of steroidal and nonsteroidal agents.

  1994cited by this paper
• Can hormone replacement therapy be used during medical therapy of endometriosis?

  1994cited by this paper
• Gonadotropin-Releasing Hormone Agonists: Treatment of Endometriosis

  1993cited by this paper
• Zoladex (Goserelin Acetate Implant) in the Treatment of Endometriosis: A Randomized Comparison With Danazol

  1993cited by this paper
• The prevention of bone loss in young women treated with GnRH analogs with ‘add‐back’ estrogen therapy

  1993cited by this paper
• An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team.

  1992cited by this paper
• Gonadotropin-releasing hormone agonists: strategies for managing the hypoestrogenic effects of therapy.

  1992cited by this paper
• Hormone treatment of endometriosis: the estrogen threshold hypothesis.

  1992cited by this paper
• Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy

  1992cited by this paper
• A comparison of nafarelin acetate and danazol in the treatment of endometriosis.

  1990cited by this paper
• Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.

  1990cited by this paper
• Treatment of Endometriosis With a Long-Acting Gonadotropin-Releasing Hormone Agonist Plus Medroxyprogesterone Acetate

  1990cited by this paper
• The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis

  1990cited by this paper
• Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results.

  1990cited by this paper
• GnRH analogues in the treatment of endometriosis.

  1989cited by this paper
• Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.

  1988cited by this paper
• Revised American Fertility Society classification of endometriosis: 1985.

  1985cited by this paper
• Revised American Fertility Society classification of endometriosis: 1985

  1985cited by this paper
• Regression of endometriosis following shorter treatment with, or lower dose of danazol: Comparison of pre‐ and post‐treatment laparoscopic findings in the Scandinavian multi‐center study

  1984cited by this paper
• Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.

  1984cited by this paper
• "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.

  1982cited by this paper

• A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action

  2024cites this paper
• Gonadotropin-releasing hormone analogues for endometriosis.

  2023cites this paper
• The impact of sex steroids on osteonecrosis of the jaw

  2022cites this paper
• Oligo-anovulation is not a rarer feature in women with documented endometriosis.

  2018cites this paper
• Medikamentöse Behandlung der Endometriose

  2018cites this paper
• Overview of elagolix for the treatment of endometriosis

  2016cites this paper
• Effects of different add-back regimens on hypoestrogenic problems by postoperative gonadotropin-releasing hormone agonist treatment in endometriosis

  2016cites this paper
• Gonadotropin-releasing hormone agonist

  2015cites this paper
• An update on the pharmacological management of endometriosis

  2013cites this paper
• The use of gonadotropin releasing hormone analogues in adolescent and young patients with endometriosis

  2013cites this paper
• Histone deacetylase inhibitors as therapeutics for endometriosis

  2012cites this paper
• Therapeutic potential of andrographolide for treating endometriosis.

  2012cites this paper
• Quality of life according to add-back therapy during GnRH agonist treatment in endometriosis patients

  2012cites this paper
• Use of Mifepristone to Treat Endometriosis: A Review of Clinical Trials and Trial-Like Studies Conducted in China

  2011cites this paper
• Levo-Tetrahydropalmatine Retards the Growth of Ectopic Endometrial Implants and Alleviates Generalized Hyperalgesia in Experimentally Induced Endometriosis in Rats

  2011cites this paper
• The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis.

  2011cites this paper
• THE AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS WOMEN’S HEALTH CARE PHYSICIANS

  2010cites this paper
• Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice.

  2010cites this paper
• Clinical trials and trial-like studies on the use of traditional Chinese medicine to treat endometriosis

  2010cites this paper
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.

  2010cites this paper
• THE AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS WOMEN’S HEALTH CARE PHYSICIANS

  2010cites this paper
• THE AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS WOMEN’S HEALTH CARE PHYSICIANS

  2010cites this paper
• A call for more transparency of registered clinical trials on endometriosis.

  2009cites this paper
• Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells.

  2009cites this paper
• Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin.

  2009cites this paper
• Capsaicin Inhibits Proliferation of Endometriotic Cells in vitro

  2008cites this paper
• Emerging drugs for endometriosis

  2008cites this paper
• Medikamentöse Schmerztherapie der Endometriose

  2008cites this paper
• WITHDRAWN: Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.

  2007cites this paper
• Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone

  2007cites this paper
• Schmerztherapeutische Optionen bei Endometriose

  2006cites this paper
• Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780

  2006cites this paper
• Emerging drugs in endometriosis

  2006cites this paper
• GnRH-antagonists in reproductive medicine

  2005cites this paper
• Dose effects of progesterone in add-back therapy during GnRHa treatment.

  2005cites this paper
• One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial.

  2004cites this paper
• Emerging drugs for endometriosis

  2004cites this paper
• Add-back therapy in the treatment of endometriosis-associated pain.

  2004cites this paper
• Medical management of endometriosis: a systematic review.

  2004cites this paper
• Medical management of endometriosis-associated pain.

  2003cites this paper
• Tratamiento de la endometriosis y medicina basada en la evidencia

  2003cites this paper
• Adolescent endometriosis.

  2003cites this paper
• Medical Therapy for Endometriosis: An Overview

  2003cites this paper
• A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy.

  2003cites this paper
• Endometriosis: Medical Treatment with Progestagens

  2003cites this paper
• Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome

  2002cites this paper
• Conventional Medical Therapies for Endometriosis

  2002cites this paper
• The medical management of endometriosis

  2002cites this paper
• The treatment of endometriosis: a review of the evidence.

  2002cites this paper
• HRT as add-back therapy

  2002cites this paper
• Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process.

  2002cites this paper
• Chronic pelvic pain: defining the scope of the problem

  2001cites this paper
• Treatment of endometriosis.

  2001cites this paper
• Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial.

  2000cites this paper
• Delayed Oral Estradiol Combined with Leuprolide Increases Endometriosis-Related Pain

  2000cites this paper
• Clinical Pharmacokinetics of Goserelin

  2000cites this paper
• A clinician's guide to the use of gonadotropin-releasing hormone analogues in women.

  2000cites this paper
• Medical management of endometriosis and infertility.

  2000cites this paper
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.

  2000cites this paper
• Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy ("draw-back" therapy).

  2000cites this paper
• ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists.

  2000cites this paper
• The role of hormone replacement therapy in women with a current or past history of endometriosis

  2000cites this paper
• Endometriozis Tedavisinde Kullanılan Gonadotropin Releasing Hormon Analogunun (Decapeptyl) Tek Başına ve Tibolon ile Birlikte Kullanımının Kemik Mineral Dansitesine Etkilerinin Karşılaştırılması

  2000cites this paper
• GnRH analogueによる子宮内膜症治療における結合型エストロゲンを用いたadd-back療法の検討

  1999cites this paper
• Molecular Biology of Gonadotropin-Releasing Hormone and the Gonadotropin-Releasing Hormone Receptor

  1999cites this paper
• Menstrual Migraine

  1999cites this paper
• WITHDRAWN: Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.

  1999cites this paper
• Current Drug Therapy Recommendations for the Treatment of Endometriosis

  1999cites this paper
• Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group.

  1999cites this paper
• Medical treatment of endometriosis.

  1999cites this paper
• GnRH Analogues and Uterine Leiomyomas

  1999cites this paper
• [Effectiveness and tolerance of a gonadotropin releasing hormone (goserelin) in treatment of symptomatic endometriosis].

  1999cites this paper
• GnRH analogues and uterine leiomyomas. Effect of hormone replacement therapy on cell proliferation.

  1999cites this paper
• Endometriosis. Current issues in diagnosis and medical management.

  1998cites this paper
• GnRH agonists and add‐back therapy: is there a perfect combination?

  1998cites this paper
• Prospective randomized study of the effect of "add-back" hormone replacement on vascular function during treatment with gonadotropin-releasing hormone agonists.

  1998cites this paper
• "Add-back" therapy for endometriosis in adolescents.

  1998cites this paper
• Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis.

  1998cites this paper
• The evidence for the management of endometriosis.

  1998cites this paper
• Leuprolide Acetate Depot and Hormonal Add‐Back in Endometriosis: A 12‐Month Study

  1998cites this paper
• Steroidal ‘Add-Back’ Therapy in Patients Treated with GnRH Agonists

  1998cites this paper
• Hormone replacement therapy following hysterectomy for endometriosis

  1998cites this paper
• Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis.

  1997cites this paper
• Progestins for symptomatic endometriosis: a critical analysis of the evidence.

  1997cites this paper
• Endometriosis--a disease because it is characterized by bleeding.

  1997cites this paper
• The Role of GnRH Agonists Plus Add-Back Therapy in the Treatment of Endometriosis

  1997cites this paper
• An exchange of ideas and "boutades".

  1996cites this paper
• Long-term treatment of endometriosis?

  1996cites this paper
• The need for add-back with gonadotrophin-releasing hormone agonist therapy.

  1996cites this paper
• Add-back therapy in the treatment of endometriosis: the European experience.

  1996cites this paper